Analyst Research

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Stock Traders Daily
$20.00
Provider: Wright Reports
$75.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Eli Lilly And Co Comments On FY 2014 Revenue Guidance; Expects To Buy Back About $5 Billion Of Shares; Maintains Current Level Dividend-Reuters


Thursday, 3 Oct 2013 07:23am EDT 

Reuters reported that Eli Lilly And Co said slowing growth in key emerging markets would make it difficult to meet its minimum revenue goal of $20 billion in fiscal 2014. Lilly also said it expected to buy back about $5 billion of shares over time and maintain its dividend at least at current levels. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $20 billion for fiscal 2014. 

Company Quote

67.36
 --
21 Nov 2014